OR WAIT null SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
July 19, 2021
A draft report from parliament's cancer committee highlights the benefits that precision and personalized medicine offer.
July 14, 2021
A broad White House proposal to advance competition in major U.S. industries features several measures intended to make medicines more affordable for patients.
July 13, 2021
Micki Hultquist, Vice President, Global Franchise Head at AstraZeneca, discusses the journey from a missed endpoint in TULIP-1 to a clinical success in TULIP-2
July 12, 2021
FDA acting commissioner Janet Woodcock has bowed to pressure and called on the HHS’s Office of the Inspector General to examine the review process for Biogen’s Alzheimer’s disease treatment, Aduhelm.
July 06, 2021
The Center for Biologics Evaluation and Research’s top priority is to approve biologics license applications (BLAs) to address vaccine hesitancy, according to CBER director Peter Marks.
June 30, 2021
The latest draft supports the creation of the Biden administration’s proposed Advanced Research Projects Agency for Health to accelerate research on cures for cancer, diabetes, Alzheimer’s and more.
June 23, 2021
Not just COVID is changing the landscape of pharmaceutical policy in Europe.
June 22, 2021
CDER launches an initiative to gain more efficient and transparent operations of its advisory panels. Jill Wechsler reports.
June 14, 2021
Thad Wolfram, President, Matrix Clinical Trials at Matrix Medical Network, speaks about his experience utilizing decentralization methodologies to increase clinical trial diversity inclusion by going deep into diverse communities.
Allegedly more than 4,000 clinical trials of medicines are missing results on the European trial registry, in violation of transparency rules.